Pathological characteristics of prostate cancer recurrence after radiation therapy: Implications for focal salvage therapy

Journal of Urology

Volumn 188, Issue 1, 2012, Pages 98-102

  Leibovici, Dan ^a   Chiong, Edmond ^b   Pisters, Louis L ^b   Guo, Charles C ^b   Ward, John F ^b   Andino, Lizmarie ^b   Prokhorova, Ina N ^b   Troncoso, Patricia ^b  

^a ASSAF HAROFEH MEDICAL CENTER   (Israel)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

local; neoplasm recurrence; prostate; prostatic neoplasms; radiotherapy; treatment failure

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SIZE; CANCER STAGING; CANCER SURGERY; CLINICAL ARTICLE; DISEASE SEVERITY; EXTERNAL BEAM RADIOTHERAPY; GLEASON SCORE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE DISSECTION; MALE; MULTIMODALITY CANCER THERAPY; PREOPERATIVE EVALUATION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; RETROSPECTIVE STUDY; SALVAGE THERAPY; TREATMENT FAILURE; URETHRA;

AGED; BIOPSY; DISEASE-FREE SURVIVAL; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; SALVAGE THERAPY; TUMOR MARKERS, BIOLOGICAL;

EID: 84862118519     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2012.02.2571     Document Type: Article

References (19)

1. A. Jemal, R. Siegel, J. Xu Cancer statistics 2010 CA Cancer J Clin 60 2010 277
2. A.B. Jani, P.A. Johnstone, S.L. Liauw Prostate cancer modality time trend analyses from 1973 to 2004: a Surveillance, Epidemiology, and End Results registry analysis Am J Clin Oncol 33 2010 168
3. D. Khuntia, C.A. Reddy, A. Mahadevan Recurrence-free survival rates after external-beam radiotherapy for patients with clinical T1-T3 prostate carcinoma in the prostate-specific antigen era: what should we expect? Cancer 100 2004 1283
4. D.A. Kuban, H.D. Thames, L.B. Levy Long-term multi-institutional analysis of stage T1-T2 prostate cancer treated with radiotherapy in the PSA era Int J Radiat Oncol Biol Phys 57 2003 915
5. M.W. Kattan, M.J. Zelefsky, P.A. Kupelian Pretreatment nomogram that predicts 5-year probability of metastasis following three-dimensional conformal radiation therapy for localized prostate cancer J Clin Oncol 21 2003 4568
6. J.I. Izawa, L.T. Madsen, S.M. Scott Salvage cryotherapy for recurrent prostate cancer after radiotherapy: variables affecting patient outcome J Clin Oncol 20 2002 2664
7. F.J. Murat, L. Poissonnier, M. Rabilloud Mid-term results demonstrate salvage high-intensity focused ultrasound (HIFU) as an effective and acceptably morbid salvage treatment option for locally radiorecurrent prostate cancer Eur Urol 55 2009 640
8. M.R. Moman, C.A. van denBerg, A.E. Boeken Kruger Focal salvage guided by T2-weighted and dynamic contrast-enhanced magnetic resonance imaging for prostate cancer recurrences Int J Radiat Oncol Biol Phys 76 2010 741
9. B. Gowardhan, D. Greene Salvage cryotherapy: is there a role for focal therapy? J Endourol 24 2010 861
10. R.F. Sanchez-Ortiz, P. Troncoso, R.J. Babaian African-American men with nonpalpable prostate cancer exhibit greater tumor volume than matched white men Cancer 107 2006 75
11. M.E. Chen, D. Johnston, A.O. Reyes A streamlined three-dimensional volume estimation method accurately classifies prostate tumors by volume Am J Surg Pathol 27 2003 1291
12. J.F. Ward Contemporary outcomes of focal therapy in prostate cancer: what do we know so far World J Urol 28 2010 593
13. J.F. Ward, J.S. Jones Classification system: organ preserving treatment for prostate cancer Urology 75 2010 1258
14. J.F. Ward, H. Nakanishi, L.L. Pisters Cancer ablation with regional templates applied to prostatectomy specimens from men who were eligible for focal therapy BJU Int 104 2009 490
15. U. Lindner, J. Trachtenberg, N. Lawrentschuk Focal therapy in prostate cancer: modalities, findings and future considerations Nat Rev Urol 7 2010 562
16. G. Onik, D. Vaughan, R. Lotenfoe The "male lumpectomy": focal therapy for prostate cancer using cryoablation results in 48 patients with at least 2-year follow-up Urol Oncol 26 2008 500
17. C.L. Amling, S.E. Lerner, S.K. Martin Deoxyribonucleic acid ploidy and serum prostate specific antigen predict outcome following salvage prostatectomy for radiation refractory prostate cancer J Urol 161 1999 857
18. S.E. Lerner, M.L. Blute, H. Zincke Critical evaluation of salvage surgery for radio-recurrent/resistant prostate cancer J Urol 154 1995 1103
19. F.J. Bianco Jr, P.T. Scardino, A.J. Stephenson Long-term oncologic results of salvage radical prostatectomy for locally recurrent prostate cancer after radiotherapy Int J Radiat Oncol Biol Phys 62 2005 448